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Background/aim: To investigate the correlation between the Glasgow-Blatchford score, shock index, and Forrest classification in
patients with peptic ulcer bleeding (PUB).
Materials and methods: A total of 955 patients with PUB were assessed using the Glasgow-Blatchford score and shock index, as well
as the Forrest classification based on their gastroscopy results. The correlation between the Glasgow-Blatchford score and shock index
was determined using scatter plot analysis, and the correlation between the Glasgow-Blatchford score or shock index and Forrest
classification was determined using Spearman’s analysis.
Results: Both the Glasgow-Blatchford score and shock index showed the highest values in patients with Forrest class IIa. The GlasgowBlatchford score was significantly higher than patients with Forrest class Ib/IIc/III (P < 0.05), and the shock index was significantly
higher than patients with Forrest class Ib/IIb/III (P < 0.05). A positive correlation was observed between the Glasgow-Blatchford score
and shock index, at r = 0.427 (P < 0.001). A negative correlation was observed between the Glasgow-Blatchford score and Forrest
classification, at r = –0.111 (P < 0.01), and between the shock index and Forrest classification, at r = –0.138 (P < 0.01).
Conclusion: A moderate correlation was observed between the Glasgow-Blatchford score and shock index in patients with PUB, and
the correlation between the Forrest classification and Glasgow-Blatchford score or shock index was relatively low.
Key words: Peptic ulcer hemorrhage, Glasgow-Blatchford score, shock index, endoscopy

1. Introduction
Acute nonvariceal upper gastrointestinal bleeding
(ANVUGIB) is one of the most severe and life-threatening
emergencies, accounting for 80%–90% of acute upper
gastrointestinal bleeding cases [1]. The common causes
of ANVUGIB include peptic ulcer, upper gastrointestinal
tumors, and acute gastric mucosal lesions, and there are
other lesions (such as a Mallory-Weiss tear, Dieulafoy
lesion, and angiodysplasia) that also cause ANVUGIB.
However, at present, peptic ulcer is still the leading cause
[2]. In recent years, several risk scores have been used to
assess the disease severity, prognosis, and clinical status
of patients with ANVUGIB, with the Glasgow-Blatchford
score (GBS) [3] being one of the most commonly used
in clinical practice. The GBS is based on clinical and
laboratory findings without endoscopy results, and was
originally designed to predict the need for treatment

(including blood transfusion, endoscopy, and surgery. The
GBS is currently used to distinguish low-risk patients from
high-risk patients, limit the use of medical resources, and
reduce hospitalization expenses [4–6].
The shock index (SI) is the ratio of the heart rate to
systolic blood pressure, and it is a clinical indicator of
hemodynamic status. The SI can be used for the initial
monitoring of patients with gastrointestinal bleeding and
define treatment and provide an early warning of persistent
bleeding or rebleeding after initial therapy [7]. Few studies
have investigated the use of the SI in assessing upper
gastrointestinal bleeding, and the relationship between the
SI and other commonly used risk scores (e.g., the GBS)
remains unclear.
Endoscopy is of great importance in the diagnosis and
treatment of ANVUGIB [8]. If ANVUGIB patients are
definitively diagnosed with peptic ulcer bleeding (PUB)
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using endoscopy, then the Forrest classification can be
determined based on the characteristics of the ulcer base.
The Forrest classification is helpful in assessing the risk of
rebleeding and can guide proper endoscopic treatment
[9–11]. While the GBS, SI, and Forrest classification are
often used to assess disease severity, no research to date
has investigated the correlation between them. The current
study investigated the correlation between the GBS, SI,
and Forrest classification in patients with PUB.
2. Materials and methods
2.1. Study design
This retrospective study considered all of the patients
with a diagnosis of PUB who were admitted to the
Affiliated Hospital of Guizhou Medical University,
Affiliated Baiyun Hospital of Guizhou Medical University,
and Cancer Hospital of Guizhou Medical University,
between January 2013 and March 2019. All of the patients
exhibited hematemesis and/or melena as the main clinical
manifestations, and underwent gastroscopy within 24 h
of admission, so as to confirm the diagnosis of PUB. The
exclusion criteria were as follows: 1) a bleeding site outside
of the upper gastrointestinal tract, 2) a malignant tumor,
and 3) the absence of the data needed to calculate the GBS.
The primary study variables were the GBS, SI, and Forrest
classification. This study was conducted in accordance
with the declaration of Helsinki and was approved by the
Medical Ethical Committee of the Affiliated Hospital of
Guizhou Medical University. Written informed consent
was obtained from all of the patients prior to their
endoscopic procedures. The STROBE guidelines were also
followed [12].
2.2. Data collection
Primary data were collected from each patient, including
their age, sex, medical history (presenting signs or
symptoms), comorbidities, use of drugs (aspirin, other
antiplatelet drugs, nonsteroidal antiinflammatory drugs
(NSAIDs), etc.), smoking, alcohol use, presence of a
Helicobacter pylori (H. pylori) infection (a positive result
in a urea breath test or rapid urease test, or histological
examination of the gastric mucosa indicating a H. pylori
infection), history of peptic ulcer or gastrointestinal
bleeding, blood pressure, pulse, heart rate, blood urea
nitrogen, hemoglobin, endoscopic findings (Forrest
classification), need for endoscopic intervention, and
treatment. Rebleeding within 7 days after initial therapy
(including endoscopic intervention) was also recorded.
The GBS was calculated for all of the patients based
on clinical and laboratory variables (e.g., systolic blood
pressure, blood urea nitrogen, hemoglobin, pulse, melena,
etc.) at the time of admission. The SI was calculated
according to the heart rate (beats/min) and systolic blood
pressure (mmHg) of the patient on admission.

Rebleeding was considered if any of the following
events occurred: the reappearance of overt bleeding (new
hematemesis or melena), a decrease in systolic blood
pressure (≤90 mmHg) or increase in pulse rate (≥110 beats
per minute), a decrease in hemoglobin (>20 g/L) within 24
h, or inadequate increase in hemoglobin (<10 g/L) after
adequate blood transfusion.
2.3. General treatment
The initial general treatment for all of the patients who
presented with acute upper gastrointestinal bleeding
and awaited endoscopy included monitoring (body
temperature, pulse, respiratory rate, blood pressure, urine
output, and mental status), bed rest, oxygen inhalation,
intravenous rehydration, and initiation of a high-dose
intravenous proton-pump inhibitor (PPI), with an
intravenous bolus of 80 mg, followed by a continuous
infusion of 8 mg/h. Assessments of the bleeding status
(characteristics, times, and total amounts of hematemesis
and/or melena) and regular reassessment with routine
blood tests, including blood urea nitrogen, were performed.
Blood transfusion was administered in accordance with
the patient’s condition. After endoscopy, patients classified
with Forrest Ia to IIb remained on high-dose PPIs via
intravenous infusion for 72 h, followed by reduction to a
standard dose (2 times each day for 3–5 days) according
to their clinical status. The same standard dose was also
used for the low-risk patients classified with Forrest IIc
and Forrest III. All of these patients who tested positive for
H. pylori infection were treated with the standard H. pylori
eradication therapy.
2.4. Endoscopy
Endoscopic procedures were performed within 24 h
on admission with a CV-260SL or CV-290 gastroscope
(Olympus, Tokyo, Japan). After the Forrest classification
of the peptic ulcer was defined via endoscopy in all of
the patients, endoscopic hemostasis was considered for
those patients with high-risk stigmata (Forrest Ia to IIb),
while it was not necessary for those with low risk (Forrest
IIc and Forrest III). Methods of endoscopic hemostasis
included epinephrine injection (epinephrine diluted
1:10,000 in 0.9% saline), electrocoagulation, argon plasma
coagulation, hemoclips, etc. The mode of therapy under
endoscopy was based on the status of the patient. All of
the endoscopic procedures were performed by expert
endoscopists who had experience with more than 500
cases of endoscopic hemostasis.
2.5. Statistical analysis
Statistical analysis was performed using SPSS v.20.0
(IBM Corp., Armonk, NY, USA). Quantitative data
with a normal distribution were expressed as the mean
± standard deviation (x̄ ± s). A comparison among
the Forrest classifications was performed with one-
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way analysis of variance, and a comparison between
the 2 groups was performed using the least significant
difference test. Qualitative data were expressed as n
(percentage), and the chi-square test and Fisher’s exact test
were used for comparisons among the rates, and the chisquare segmentation method was used for comparisons
between the 2 groups, with an adjustment of the test
level for the rates between the 2 groups to α = 0.0033.
The association between GBS and SI was evaluated using
Pearson’s correlation analysis, and the association between
the GBS/SI and the Forrest classification was evaluated
using Spearman’s rank correlation analysis. P < 0.05 was
considered statistically significant.
3. Results
3.1. Patient characteristics
Between January 2013 and March 2019, a total of 1060
patients with PUB were admitted to the abovementioned
institutions. Among those admitted, 24 patients with
bleeding sites outside of their upper gastrointestinal
tract, 36 with malignant tumors, and 45 without the data
required to calculate the GBS were excluded. Finally, a

total of 955 patients with PUB were enrolled in this study
(Figure 1). The mean age was 57.16 ± 15.12 years, and
the group included 701 males (73.40%) and 254 females
(26.60%).
Hypertension was present in 286 patients (29.95%),
rheumatic disease in 146 (15.29%), diabetes mellitus in 69
(7.23%), and chronic kidney disease in 55 (5.76%). NSAIDs
(excluding aspirin) were used in 36.75% of patients, and
aspirin was used in 3.46%. Other characteristics, such as
smoking, alcohol use, H. pylori infection, history of peptic
ulcer, or gastrointestinal bleeding, are shown in Table 1.
3.2. Endoscopic data
Endoscopic examination was performed within 24 h of
admission in the 955 patients with PUB in the current
study. In Figure 1, it can be seen that 15 patients were
classified with Forrest Ia, 81 with Forrest Ib, 88 with Forrest
IIa, 76 with Forrest IIb, 36 with Forrest IIc, and 659 with
Forrest III. Other than the patients with Forrest IIc and
Forrest III, all of those with Forrest Ia and most of those
with Forrest Ib to IIb underwent endoscopic hemostasis,
which included monotherapy and combination therapy
(details in Table 2).

Figure 1. Flowchart showing the flow of patients through the study. Peptic ulcer bleeding (PUB), Glasgow-Blatchford score
(GBS).
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Table 1. Characteristics of patients with PUB (n = 955).
Patient characteristics
Age, years, mean ± SD

57.16 ± 15.12

Sex, n (%)
Male

701 (73.40)

Female

254 (26.60)

Comorbidities, n (%)
Hypertension

286 (29.95)

Diabetes mellitus

69 (7.23)

Heart failure

27 (2.83)

Cerebrovascular disease

49 (5.13)

Respiratory disease

39 (4.08)

Hepatic disease

44 (4.61)

Chronic kidney disease

55 (5.76)

Rheumatic disease

146 (15.29)

Concomitant drug use, n (%)
Aspirin

33 (3.46)

Other anti-platelet drugs

19 (1.99)

NSAIDs (excluding aspirin)

351 (36.75)

Warfarin

5 (0.52)

Corticosteroids

24 (2.51)

Smoking, n (%)

462 (48.38)

Alcohol use, n (%)

399 (41.78)

Helicobacter pylori infection, n (%)
Negative

212 (22.20)

Positive

427 (44.71)

Unknown

316 (33.09)

History of peptic ulcer, n (%)

131 (13.72)

History of gastrointestinal bleeding, n (%)

119 (12.46)

NSAIDs: nonsteroidal antiinflammatory drugs

3.3. Comparison among the different Forrest
classifications
No significant differences in the age and sex of the patients
were found with different the Forrest classifications (P >
0.05, Table 3). The comparison of the GBS/SI/rebleeding
rates among the different Forrest classifications showed
statistical significance (P < 0.05). Both the GBS and SI
showed a peak value in patients with Forrest IIa, and
the GBS was significantly higher in patients with Forrest
IIa than in those with Ib/IIc/III (P < 0.05), while SI was
significantly higher in Forrest IIa than Ib/IIb/III (P < 0.05).
There was no statistically significant difference in the GBS/
SI among the other Forrest classifications (P > 0.05). The
total rebleeding rate was 4.08%; the rebleeding rate in

Forrest Ia (20.00%) was higher than in Forrest III (1.67%),
with statistical significance (P < 0.0033); the rebleeding
rate in Forrest Ib (3.70%) was lower than in Forrest IIa
(21.59%), with statistical significance (P < 0.0033); and the
rebleeding rate in Forrest IIa was higher than in Forrest
IIb/IIc/III, also with statistical significance (P < 0.0033)
(Table 3).
3.4. Correlation analysis between the GBS and SI
The GBS-SI scattering dot curves showed clustering using
the curve imitation method. Pearson’s analysis revealed
that the GBS was positively correlated with the SI (P <
0.001), at r = 0.427 (Figure 2).
3.5. Correlation analysis between the GBS /SI and the
Forrest classification
Spearman’s rank analysis revealed a negative correlation
between the GBS and Forrest classification, at r = –0.111
(P < 0.01), and between the SI and Forrest classification, at
r = –0.138 (P < 0.01).
4. Discussion
According to reports, the incidence of PUB ranges from
20 to 60/100,000 people and the mortality rate remains at
5%–10%, despite advances in endoscopy and medication
[13]. Early assessment of the disease severity and prognosis
has become increasingly important. In this study, it
was determined that the GBS in patients with PUB was
positively correlated with the SI, the correlation between
the Forrest classification and the GBS or SI was relatively
low; the GBS, SI, and the rebleeding rates in patients with
Forrest Ib were significantly lower than in those with
Forrest IIa.
The application value of the GBS in assessing the
condition of a patient, need for intervention, and
evaluation of the prognosis for patients with upper
gastrointestinal bleeding has been confirmed by numerous
studies [14–16]. The European Society of Gastrointestinal
Endoscopy has recommended assessment using the
GBS before endoscopy, with low-risk (GBS 0–1) patients
not requiring early endoscopy or hospitalization [17].
Some studies have found that the GBS can better predict
rebleeding in patients with upper gastrointestinal bleeding
[18–20], and a high GBS (GBS > 7) is associated with the
risk of rebleeding [21].
The SI can provide a comprehensive assessment of
cardiovascular status and can be used to estimate the
amount of blood loss and degree of shock (normal range:
0.5 to 0.7) [7]. A study by Rassameehiran et al. showed that
the SI was a good tool to identify patients with the potential
for short-term adverse outcomes when they presented with
upper gastrointestinal bleeding, and the SI was performed,
as well as other risk-scoring tools, for gastrointestinal
bleeding [22]. In this study, it was determined that the GBSs
of patients with PUB were positively correlated with the SI,
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Table 2. Endoscopic treatment.
Forrest classification

Endoscopic treatment, n (%)

Type of endoscopic treatment

Ia (n = 15)

15 (100.00)

Monotherapy, n = 2 (13.33%)
Combination therapy, n = 13 (86.67%)

Ib (n = 81)

75 (92.59)

Monotherapy, n = 20 (26.67%)
Combination therapy, n = 55 (73.33%)

IIa (n = 88)

82 (93.18)

Monotherapy, n = 24 (29.27%)
Combination therapy, n = 58 (70.73%)

IIb (n = 76)

51 (67.11)

Monotherapy, n = 12 (23.53%)
Combination therapy, n = 39 (76.47%)

IIc (n = 36)

0 (0.00)

-

III (n = 659)

0 (0.00)

-

Monotherapy: epinephrine injection, argon plasma coagulation, or hemoclips; combination therapy:
combining epinephrine injection with argon plasma coagulation and/or hemoclips.

Table 3. Comparison among different Forrest classifications.
Variable

Ia (n = 15)

Ib (n = 81)

IIa (n = 88)

IIb (n = 76)

IIc (n = 36)

III (n = 659)

F/c2

P

Age (years), mean ± SD 63.27 ± 13.13

54.23 ± 17.04 58.98 ± 13.26 57.25 ± 15.95 57.64 ± 15.45 57.10 ± 15.01

1.362

0.236

Sex (male/female)

13/2

64/17

73/15

27/9

469/190

8.544

0.129

GBS, mean ± SD

9.80 ± 3.26

9.40 ± 3.18a

10.58 ± 3.39cd 9.66 ± 3.36

8.75 ± 3.64

8.95 ± 3.34

4.315

0.001

SI, mean ± SD

0.81 ± 0.18

0.79 ± 0.21a

0.85 ± 0.19bd

0.79 ± 0.21

0.79 ± 0.17

0.75 ± 0.18

5.686

<0.001

Rebleeding, n (%)

3 (20.00)

3 (3.70)

19 (21.59)

3 (3.95)

0 (0.00)

11 (1.67)

89.935

<0.001*

55/21

Compared with Forrest IIa, P < 0.05; b compared with Forrest IIb, P < 0.05; c compared with Forrest IIc, P < 0.05; d compared with Forrest
III, P < 0.05; *P < 0.05, the test level α’ of the pairwise comparison ratio was = 0.0033 (P: subgroup Ia vs. subgroup III: 0.003, subgroup
Ib vs. subgroup IIa: 0.001, subgroup IIa vs. subgroup IIb: 0.001, subgroup IIa vs. subgroup IIc: 0.002, and subgroup IIa vs. subgroup III:
<0.001);
GBS: Glasgow-Blatchford score; SI: shock index.
a

Figure 2. Glasgow-Blatchford score-shock index scattering dots
curve.
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i.e., the higher the SI, the higher the GBS. Clinically, the
SI can be more easily calculated than the GBS. Therefore,
emergency patients should first be assessed with the SI
to determine their disease severity, and the GBS may be
used to further assess their disease severity and prognosis
after the completion of blood and other tests, as it may
be helpful for risk stratification and decision-making
clinically before endoscopy.
With the wider application and higher importance of
emergency endoscopy, identifying the cause of bleeding as
early as possible via endoscopy is of great significance for
the diagnosis and treatment in ANVUGIB patients [8,23].
The Forrest classification is an endoscopic scoring system,
which classifies ulcer lesions into high-risk and low-risk,
and it is helpful in predicting the risk of rebleeding and
guiding endoscopic hemostasis therapy [17]. At present,
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the analysis of risk factors on adverse outcomes of
ANVUGIB patients [24] and the comparison of the GBS
with other risk scores (e.g., Rockall score, AIMS65, etc.)
in predicting the prognosis of ANVUGIB patients are still
hot topics, and some other researchers have reported the
application value of the GBS and Forrest classification in
Mallory-Weiss syndrome [25]. However, the correlation
between the clinical severity score (such as the GBS and
SI) and the severity of endoscopic manifestations (Forrest
classification) in patients with PUB has not been reported.
The study herein explored the correlation between the
GBS or SI before endoscopy and the Forrest classification
after endoscopy, and it was found that the correlation
between the Forrest classification and GBS or SI was
relatively low. The r values were only –0.111 and –0.138,
respectively, with several possible explanations, as follows:
1) Due to the small sample size, with only 15 patients
(1.57%) with Forrest class Ia, we could not perform
adequate investigation on those with a high rebleeding
risk; thus, a larger sample and further research are needed.
2) PPIs are important in the treatment of PUB. Moreover,
preendoscopy PPI treatment can improve the condition of
a bleeding peptic ulcer and reduce the need for endoscopic
treatment [26,27]. All of the patients in the current study
used PPIs prior to gastroscopy, possibly reducing the
Forrest grade of the patients. 3) As heart rates and blood
pressures of the patients changed dynamically, performing
dynamic monitoring to determine the SI may be preferred.
In addition, the study showed that Forrest Ib patients
had lower a GBS and SI than those with Forrest IIa before
endoscopic examination, the rebleeding rate in the Forrest
Ib patients was lower than in those with Forrest IIa after
initial treatment (including endoscopic hemostasis), and
the rebleeding rate in patients with Forrest Ib (3.70%) was
indeed low after initial treatment, which was consistent
with recent findings [28], but the value of the Forrest Ib
classification as a sign of high-risk ulcers may need to be
reevaluated.
There were several limitations in this study: 1) This was
a retrospective study, and the sample was small; thus, a
larger sample and prospective study are needed to confirm
the results. 2) H. pylori infection is the main cause of peptic

ulcer. The eradication of H. pylori is closely related with
the prognosis of patients with peptic ulcer, e.g., rebleeding,
and it can promote ulcer healing. In this study, 427 patients
(44.71%) tested positive for H. pylori and were treated with
the standard H. pylori eradication therapy, but the efficacy
of the therapy was not followed up. At the same time,
patients who had tested negative for H. pylori infection
during bleeding were not rechecked, and some patients
did not have any test results for H. pylori. Hence, future
studies should pay close attention to H. pylori eradication
therapy as well as its effect on the prognosis of the patient.
3) Different endoscopists and methods used for endoscopic
hemostasis may have influenced the rebleeding rate. 4) The
study did not compare the comorbidities of the different
Forrest classifications, and as comorbidities are risk factors
for rebleeding, further studies are needed to analyze the
rebleeding rates and risk factors corresponding to the
Forrest classifications. 5) The incidence of rebleeding was
only recorded for 7 days after the initial treatment; hence,
longer-term follow-up of the rebleeding rate, e.g., over 30
days, may be necessary.
In conclusion, the moderate correlation between
the GBS and SI may be helpful for risk stratification and
clinical decision making before endoscopy. Correlation
between the Forrest classification and the GBS or SI was
relatively low.
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